Due to the structural similarity of insulin, proinsulin, insulin-like growth factor-I (IGF-I) and IGF-II and resemblances of the insulin and IGF-I receptor, IGF-I was proposed as another treatment option for patients with severe insulin resistance [19,20,21]. The gene discussed is INS; the disease is Insulin resistance.